Gamal Boutros
Neurology · Johnson City, TNNPI 1235168949
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by UCB, Inc. at 33.2% of the total. Reporting peaked in 2021 at $995 and has fallen 97.9% since, to $21 in 2025. That places this record below the midpoint for neurology clinicians in TN, where the typical reported total is $2,246.
Across 164 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$930
- Amgen$261
- AbbVie$244
- Eisai Inc.$136
- Johnson & Johnson$118
- Greenwich Biosciences, Inc.$115
- plus $999 from 20 others
What the payments were for
- Food & beverage$2,72997%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 53 | $930 |
| Amgen | 8 | $261 |
| AbbVie(2 entities) | 21 | $244 |
| Eisai Inc. | 7 | $136 |
| Johnson & Johnson | 3 | $118 |
| Greenwich Biosciences, Inc. | 12 | $115 |
| SK Life Science, Inc. | 5 | $110 |
| Neurelis, Inc. | 4 | $88 |
| Neurocrine Biosciences, Inc. | 6 | $83 |
| Lilly USA, LLC | 6 | $82 |
| Acadia Pharmaceuticals Inc | 5 | $72 |
| Novartis | 5 | $71 |
| Biogen | 4 | $69 |
| Supernus Pharmaceuticals, Inc. | 4 | $61 |
| Adamas Pharmaceuticals, Inc. | 2 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Genentech USA, Inc. | 3 | $42 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Livanova USA, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Pfizer | 2 | $25 |
| AstraZeneca | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| MDD US Operations, LLC | 1 | $16 |
| Catalyst Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIMOVIG$115
How this compares
$2,804 in reported general payments places this provider in the 50th percentile of 361 neurology providers in Tennessee.
Other neurology in Johnson City
- Nathaniel WhaleyJohnson City$139K
- Samuel HunterSpring Hill$676K
- Harold MosesNashville$438K
- Lucas ElijovichMemphis$415K
- David BrandesKnoxville$412K
- Sibyl WrayKnoxville$377K
- Christine HagenAlcoa$371K
- Mark LedouxMemphis$352K
- Christopher PendolaKingsport$344K
- Daniel ClaassenNashville$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.